In patients with HIV, alcohol reduction after a 6-month intervention and adherence to isoniazid had no effect on the high ...

Real-world analyses have confirmed the efficacy of the 2-drug regimen of dolutegravir and lamivudine in treating HIV, confirming phase 3 testing results.

The following is a summary of “Unconventional use of injectable long-acting cabotegravir and rilpivirine against HIV-1 in PWH ...

The primary outcomes were viral suppression (VS; HIV RNA viral load < 50 copies/mL at 96 weeks post-ART initiation) and virological failure (VF; two consecutive HIV RNA viral load levels > 50 ...

Caring for HIV-positive mothers after childbirth is critical, particularly when discussing the health of both the mother and ...

The decrease in CD4 cells during HIV ... suppression with antiretroviral therapy (ART). Occasionally, we also see surprisingly low CD4-cell counts among patients who control viral replication ...

After 48 weeks of treatment, viral suppression rates were comparable between ... to mitigate an anticipated drop in sales for its HIV portfolio owing to an erosion of market share for the Atripla ...

"For now, all HIV/AIDS programmes continue. As the South African government, we want to emphasize that nobody must stop ...

People will no longer receive condoms to prevent new HIV infections and sexually transmitted infections.

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...

European Commission authorises ViiV Healthcare’s long-acting injectable Vocabria plus Rekambys for HIV treatment in adolescents: London, UK Saturday, February 1, 2025, 11:00 Hrs ...